Skip to main content

Want a detailed portfolio tracker?

Enlivex (ENLV) P/E (2019 - 2026)

Enlivex (ENLV) P/E from Dec 31, 2019 to Jul 21, 2026. The TTM Enlivex (ENLV) P/E is 0.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Enlivex (ENLV)

YearP/EChange
20260.06-55.16%
20250.14-100.49%
2024-27.65+15.12%
2023-24.02-39.84%
2022-39.93-37.00%
2021-63.37-23.90%
2020-83.27+12.54%
2019-73.99N/A

Comparison Enlivex (ENLV) P/E with competitors

Enlivex (ENLV) P/E is 0.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-97.20%
NBYStablecoin Development Corp0.00-92.91%
FGENFibroGen Inc0.24+296.00%
CHRSCoherus Biosciences Inc0.85+1299.82%
FBIOFortress Biotech Inc0.95+1465.62%
ORMPOramed Pharmaceuticals Inc1.50+2379.58%
AGENAgenus Inc3.01+4864.94%
INVAInnoviva Inc3.15+5103.16%
VXRTVaxart Inc3.55+5755.97%
CRMDCorMedix Inc3.63+5885.81%
CVACCureVac N.V.4.45+7233.99%
GLPGGalapagos NV4.86+7915.66%
SRPTSarepta Therapeutics Inc4.88+7953.94%
ABEOAbeona Therapeutics Inc5.39+8787.73%
ABUSArbutus Biopharma Corp5.60+9131.04%
ZVRAZevra Therapeutics Inc5.89+9612.11%
SPROSpero Therapeutics Inc6.23+10175.00%
CGENCompugen Ltd6.31+10316.06%
RIGLRigel Pharmaceuticals6.87+11236.79%
SLXNSilexion Therapeutics Corp7.30+11936.28%
OMEROmeros Corporation9.26+15174.09%
AUPHAurinia Pharmaceuticals Inc9.58+15712.24%
PLXProtalix BioTherapeutics Inc10.89+17866.82%
ACADAcadia Pharmaceuticals Inc11.73+19248.49%
TBPHTheravance Biopharma Inc12.26+20128.80%
ADMAAdma Biologics Inc12.42+20386.16%
HRMYHarmony Biosciences Holdings Inc13.82+22699.12%
SABSSAB Biotherapeutics Inc14.14+23220.44%
NAGENiagen Bioscience Inc14.82+24345.41%
INCYIncyte Corp15.82+26002.42%
REGNRegeneron Pharmaceuticals Inc15.86+26058.68%
PBYIPuma Biotechnology Inc17.32+28465.67%
CPRXCatalyst Pharmaceuticals Inc17.44+28669.58%
EXELExelixis Inc17.54+28832.41%
TGTXTG Therapeutics Inc18.97+31188.26%
MDXGMimedx Group Inc20.55+33805.43%
XOMAXOMA Royalty Corp22.87+37637.32%
ARGXArgen X SE24.30+39985.42%
CTMXCytomX Therapeutics Inc24.82+40848.40%
XOMAOXOMA Royalty Corp25.34+41712.38%
HALOHalozyme Therapeutics Inc25.62+42172.50%
XOMAPXOMA Royalty Corp25.67+42249.05%
VRTXVertex Pharmaceuticals Inc27.99+46084.07%
RPRXRoyalty Pharma plc - Class A28.69+47227.02%
SLNOSoleno Therapeutics Inc29.02+47767.81%
ASNDAscendis Pharma A/S30.09+49533.37%
LGNDLigand Pharmaceuticals Inc - Class B37.91+62445.02%
APLSApellis Pharmaceuticals Inc39.02+64274.93%
BMRNBiomarin Pharmaceutical Inc42.21+69538.63%
KRYSKrystal Biotech Inc45.34+74705.01%
ONCBeiGene Ltd69.54+114623.80%
PHARPharming Group N.V.75.03+123672.87%
TECHBio-Techne Corp101.96+168105.06%
VCELVericel Corp109.92+181241.89%
ALNYAlnylam Pharmaceuticals Inc117.96+194512.03%
GMABGenmab140.29+231343.63%
TLXTelix Pharmaceuticals Ltd162.15+267410.41%
CORTCorcept Therapeutics Inc212.86+351060.09%